Nonetheless, while GNAQ mutations have been reported in KHE, their exact contribution to tumor development remains unclear, and it is still debated whether they represent a primary driver or a secondary event [17]. This evidence concerns the gene GNAQ and kaposiform hemangioendothelioma.